400 results on '"Radhakrishnan, Rajiv"'
Search Results
2. The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [11C]UCB-J
3. Cognitive functioning and functional ability in women with schizophrenia and homelessness
4. A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression
5. PET Biomarkers in Psychiatry
6. Cannabis and Psychosis Proneness
7. Illness Phase as a Key Assessment and Intervention Window for Psychosis
8. Role of Psychedelics in Treatment-Resistant Depression
9. Age, gender and body-mass-index relationships with in vivo CB1 receptor availability in healthy humans measured with [11C]OMAR PET
10. The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
11. PET Imaging of Synaptic Vesicle Protein 2A
12. Effects of Age and BMI on Histamine H3 Receptor Availability in Healthy Humans
13. 37. The Structural Connectome Constrains in Vivo Synaptic Density Loss in Schizophrenia
14. In vivo evidence of lower synaptic vesicle density in schizophrenia
15. Identifying brain networks in synaptic density PET (11C-UCB-J) with independent component analysis
16. Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder
17. Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis
18. In vivo 5-HT6 and 5-HT2A receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [11C]GSK215083 PET
19. A systematic review of approaches to improve medication adherence in homeless adults with psychiatric disorders
20. Enhancing Access to Situational Vocabulary by Leveraging Geographic Context
21. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial
22. Comparison of Semantic versus Syntactic Message Formulation: A Pilot Study
23. Effects of Buprenorphine, Methadone and Substance-Use on COVID-19 Morbidity and Mortality
24. The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [11C]UCB-J
25. PET Imaging of Synaptic Vesicle Protein 2A
26. Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans
27. In Vivo Synaptic Density in Early Schizophrenia: Are There No Differences or Are They Too Small to Detect?
28. Characterization of an extreme phenotype of schizophrenia among women with homelessness
29. International perspective on physician knowledge, attitude and practices related to medical cannabis
30. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information
31. The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [11C]UCB-J.
32. Impact of personal beliefs about medical cannabis on physician recommendation practices: Results of an international survey
33. Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosis
34. Neuropsychiatric aspects of concussion
35. Asian Indians in America: The influence of values and culture on mental health
36. Reduced Brain Cannabinoid Receptor Availability in Schizophrenia
37. Human Laboratory Studies on Cannabinoids and Psychosis
38. Introduction
39. Contributors
40. Psychotomimetic and Cognitive Effects of Δ 9 -Tetrahydrocannabinol in Laboratory Settings
41. Treatment of Psychiatric Disorders
42. Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosis.
43. A Meta-analytic Review of Non-specific Effects in Randomized Controlled Trials of Cognitive Remediation for Schizophrenia
44. Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosis
45. Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes
46. Editorial: Gone to Pot: Examining the Association Between Cannabis Use and Medical/Psychiatric Disorders
47. Letters.
48. Illness Phase as a Key Assessment and Intervention Window for Psychosis
49. P520. Mediation Analysis of the Relationship Between Cannabis Use, Affective Symptoms and the Association With Psychosis: Further Support for an Affective Pathway to Psychosis
50. Illness Phase as a Key Assessment and Intervention Window for Psychosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.